Publication
Fatal Central Nervous System Lymphocytic Vasculitis after Treatment for Burkitt Lymphoma in a Patient with a SH2D1A Mutation
dc.contributor.author | Neves, JF | |
dc.contributor.author | Raga, LT | |
dc.contributor.author | Chiang, SCC | |
dc.contributor.author | Tesi, B | |
dc.contributor.author | Vieira, JP | |
dc.contributor.author | Cordeiro, AI | |
dc.contributor.author | Borrego, L | |
dc.contributor.author | Bryceson, YT | |
dc.date.accessioned | 2021-04-29T18:55:55Z | |
dc.date.available | 2021-04-29T18:55:55Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Very rarely, patients with X-linked lymphoproliferative syndrome type 1 present central nervous system vasculitis. We report a patient carrying a SH2D1A mutation that, after treatment for lymphoma developed fatal central nervous system vasculitis. He lacked signs of ongoing Epstein-Barr virus infection. We propose that impaired T cell homeostasis caused by SAP deficiency facilitates aberrant CD8 T cell activation against vascular antigens promoting clinical manifestations. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Pediatr Infect Dis J . 2019 Feb;38(2):e29-e31 | pt_PT |
dc.identifier.doi | 10.1097/INF.0000000000002154 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/3677 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wolters Kluwer Health | pt_PT |
dc.subject | Adolescent | pt_PT |
dc.subject | Aftercare | pt_PT |
dc.subject | Burkitt Lymphoma | pt_PT |
dc.subject | Central Nervous System Diseases | pt_PT |
dc.subject | Fatal Outcome | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Signaling Lymphocytic Activation Molecule Associated Protein | pt_PT |
dc.subject | Vasculitis | pt_PT |
dc.subject | Mutation | pt_PT |
dc.subject | HDE NEU PED | pt_PT |
dc.subject | HDE PED | pt_PT |
dc.title | Fatal Central Nervous System Lymphocytic Vasculitis after Treatment for Burkitt Lymphoma in a Patient with a SH2D1A Mutation | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | e31 | pt_PT |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | e29 | pt_PT |
oaire.citation.title | The Pediatric infectious disease journal | pt_PT |
oaire.citation.volume | 38 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ped Infect Dis J 2019_e29.pdf
- Size:
- 293.93 KB
- Format:
- Adobe Portable Document Format